摘要
目的探讨三七总皂苷在慢性阻塞性肺病急性加重期(AECOPD)中的应用。方法 73例AECOPD患者随机分为治疗组与对照组。两组患者均给予常规治疗,治疗组加用三七总皂苷0.45静滴,每天一次。观察两组病人治疗前,治疗后血液流变学.症状改善.指脉氧等。结果治疗组与对照组患者在血液流变学.症状改善.指脉氧等存在显著性差异(P<0.05)结论对AECOPD的患者使用三七总皂苷,可明显改善患者的肺功能.血液流变学及减轻临床症状。
Objective To investigate the clinical application of panax notoginseng saponins in the treatment of patients with chro- nic obstructive pulmonary disease at acute exacerbation stage （AECOPD）. Methods 73 AECOPD patients were all given conventional treatment and then randomly divided into two groups. The treatment group were intravenously dripped with 0. 45 g of panax notoginseng saponins once a day. The hemorheology was analyzed. Results The improvement was more pronounced in the treatment group than in the control group with significant difference （ P 〈 0.05）. Conclusion Panax notoginseng saponins can significantly improve lung functions and reduce the clinical symptoms in the treatment of COPD patients at acute exacerbation stage.
出处
《临床肺科杂志》
2013年第3期515-515,522,共2页
Journal of Clinical Pulmonary Medicine
关键词
慢性阻塞性肺病
急性加重期
三七总皂苷
chronic obstructive pulmonary disease
acute exacerbation stage
panax notoginseng saponins
